Article
Molecular phenotype is associated with survival in breast cancer patients with spinal bone metastases.
Clinical & experimental metastasis - 1 Jan 2015
Bollen L, Wibmer C, Wang M, van der Linden Y M, Leithner A, Bünger C E, Jensen A B, Fiocco M, Bratschitsch G, Pondaag W, Bovée J V M G, Dijkstra P D S
Abstract excerpt
To aid in therapy selection for patients with spinal bone metastases (SBM), predictive models have been developed. These models consider SBM from breast cancer a positive predictive factor, but do not take phenotypes based on estrogen (ER), progesterone (PR) and human epidermal growth factor 2 (HER2) receptors into account. The aim of this study was to ascertain whether receptors are associated with survival,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.